Clinical trial
Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients…
NCT00026273 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00026273 |
|---|---|
| Title | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer |
| Official title | Multicenter Phase III Open Label Randomized Trial Comparing CPT-11 In Combination With A 5-FU/FA Infusional Regimen To The Same 5-FU/FA Infusional Regimen Alone As Adjuvant Treatment Of Stage III Colon Cancer |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | FOLFIRI regimen, fluorouracil, irinotecan hydrochloride, leucovorin calcium |
| Start date | Jan 1, 2001 |
| Primary completion | Sep 1, 2004 |
| First posted | Aug 5, 2003 |
| Last update posted | Aug 7, 2012 |
| Countries | Austria, Belgium, Egypt, France, Germany, Italy, Portugal, Spain, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: